In a patient with grade 1 diastolic dysfunction, normal left‑atrial volume index (21 mL/m²) and resting E/e′ of 9.2, no exertional dyspnea or orthopnea, and peripheral edema due to venous insufficiency, should a stress echocardiogram be performed now to monitor filling pressures, given the limited reliability of E/e′, and what E/e′ threshold would indicate progression to heart‑failure with preserved ejection fraction?

Stress Echocardiography in Grade 1 Diastolic Dysfunction Without Exertional Symptoms

In this patient with grade 1 diastolic dysfunction, normal left-atrial volume, resting E/e′ of 9.2, and no exertional dyspnea or orthopnea, stress echocardiography is not indicated at this time because the test is specifically reserved for patients with unexplained exertional symptoms when resting parameters do not explain dyspnea. 1

When Stress Echocardiography Is and Is Not Indicated

Current Clinical Status

• Your patient has no exertional dyspnea or orthopnea, which are the cardinal symptoms that trigger consideration of diastolic stress testing 1
• The peripheral edema is explained by venous insufficiency, not cardiac dysfunction 1
• Resting echocardiographic parameters are reassuring: E/e′ of 9.2 indicates normal filling pressures at rest, and LA volume index of 21 mL/m² is well below the abnormal threshold of 34 mL/m² 1, 2

Specific Indications for Diastolic Stress Testing

Stress echocardiography for diastolic dysfunction is indicated only when:

• The patient has unexplained exertional dyspnea, breathlessness, or fatigue 1
• Resting diastolic parameters are borderline or inconclusive and do not explain the symptoms 1
• The goal is to detect exercise-induced elevation of filling pressures that causes symptoms 1, 2

When Stress Testing Should NOT Be Performed

Diastolic stress testing is contraindicated or inappropriate when:

• Filling pressures are already elevated at rest (the cardiac etiology is established) 1, 2
• Diastolic function is completely normal at rest with septal e′ > 7 cm/s, lateral e′ > 10 cm/s, and no symptoms 3, 4
• The patient has no exertional symptoms to explain 1

Reliability of E/e′ for Assessing Filling Pressures

Limitations at Rest

You are correct that E/e′ has significant limitations:

• A 2016 meta-analysis found that resting E/e′ has poor to mediocre linear correlation with invasively measured filling pressures in preserved ejection fraction 5
• Using ASE-recommended cutoffs, septal E/e′ had only 24% sensitivity for detecting elevated filling pressures, though specificity was 98% 5
• The positive likelihood ratio was <5 for lateral and mean E/e′, indicating limited diagnostic utility 5

Superior Performance During Exercise

However, E/e′ performs substantially better during exercise stress:

• Exercise E/e′ correlates strongly with invasively measured pulmonary capillary wedge pressure and left-atrial pressure during exertion 2
• Exercise E/e′ provides superior prognostic information compared with resting parameters 2
• In patients with grade 1 diastolic dysfunction, the inability to augment e′ velocity during exercise leads to a marked rise in E/e′ that reliably identifies elevated filling pressures 1, 2

Why Exercise Testing Is More Reliable

• Patients with grade 1 diastolic dysfunction cannot augment myocardial relaxation during exercise as healthy subjects do, so they must increase filling pressures to meet cardiac output demands 2
• In normal subjects, both E and e′ rise proportionally during exercise, keeping E/e′ stable at 6–8 1, 3
• In grade 1 dysfunction, E rises while e′ remains unchanged or increases minimally, causing E/e′ to climb markedly 1, 2, 3

E/e′ Threshold Indicating Progression to HFpEF

Diagnostic Criteria During Exercise

The test is definitively abnormal when ALL three conditions are met: 1

• Average E/e′ > 14 or septal E/e′ > 15 with exercise
• Peak tricuspid regurgitation velocity > 2.8 m/s with exercise
• Septal e′ velocity < 7 cm/s (or lateral e′ < 10 cm/s) at rest

Specific Threshold for Your Patient

• Starting from a resting E/e′ of 9.2, progression to HFpEF would be indicated by an exercise E/e′ rising to >15 (septal) or >14 (average) 1, 2
• This represents an increase of approximately 6 points from baseline 2
• Even patients achieving high workloads (e.g., Bruce stage 4) may have markedly elevated filling pressures during exercise, so excellent exercise capacity does not exclude the diagnosis 2

Additional Prognostic Markers

• Exercise E/e′ > 13 combined with systolic pulmonary artery pressure ≥ 50 mmHg are markers of adverse outcomes 1, 3
• A rise in E/e′ during exercise that persists into early recovery (even if not measured at peak) also indicates abnormal diastolic reserve 1

Recommended Monitoring Strategy for This Patient

Current Approach

Serial echocardiographic reassessment every 6–12 months is appropriate to detect progression of diastolic dysfunction 3

Triggers for Stress Testing

Perform stress echocardiography if:

• The patient develops exertional dyspnea, orthopnea, or exercise intolerance 1, 4
• Resting E/e′ rises to the borderline range (10–14) and symptoms emerge 1, 2
• There is clinical suspicion that symptoms are cardiac despite normal resting parameters 1, 4

Preferred Protocol When Testing Becomes Indicated

• Use supine bicycle ergometry to allow continuous acquisition of mitral inflow, mitral annular tissue Doppler, and tricuspid regurgitation velocities at baseline, each exercise stage, and early recovery 1
• Treadmill exercise is acceptable, with Doppler measurements obtained in early recovery when E and A waves are separated 1, 4

Common Pitfalls to Avoid

• Do not perform stress testing in asymptomatic patients with normal or mildly abnormal resting diastolic function—the test is designed to explain exertional symptoms, not to screen for subclinical disease 1, 4
• Do not rely solely on resting E/e′ to exclude diastolic dysfunction as a cause of exertional dyspnea when symptoms are present, because resting parameters correlate poorly with exercise capacity 2, 4
• Do not interpret isolated biomarker elevation (e.g., BNP 100–400 pg/mL) as diagnostic of HFpEF without corroborating echocardiographic or invasive data, as BNP falls into a "gray zone" in preserved ejection fraction 2
• Document body mass index and serum creatinine with any natriuretic peptide measurement, as obesity lowers concentrations by 20–30% and renal impairment raises levels 2